Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis.

Journal: JCO clinical cancer informatics
Published Date:

Abstract

PURPOSE: Most individuals with a hereditary cancer syndrome are unaware of their genetic status to underutilization of hereditary cancer risk assessment. Chatbots, or programs that use artificial intelligence to simulate conversation, have emerged as a promising tool in health care and, more recently, as a potential tool for genetic cancer risk assessment and counseling. Here, we evaluated the existing literature on the use of chatbots in genetic cancer risk assessment and counseling.

Authors

  • Emily M Webster
    Weill Cornell Medicine, New York, NY.
  • Muhammad Danyal Ahsan
    Weill Cornell Medicine, New York, NY.
  • Luiza Perez
    Weill Cornell Medicine, New York, NY.
  • Sarah R Levi
    Weill Cornell Medicine, New York, NY.
  • Charlene Thomas
    Weill Cornell Medicine, New York, NY.
  • Paul Christos
    Weill Cornell Medicine, New York, NY.
  • Andy Hickner
    Weill Cornell Medicine, New York, NY.
  • Jada G Hamilton
    Memorial Sloan Kettering Cancer Center, New York, NY.
  • Kemi Babagbemi
    Weill Cornell Medicine, New York, NY.
  • Evelyn Cantillo
    Weill Cornell Medicine, New York, NY.
  • Kevin Holcomb
    Weill Cornell Medicine, New York, NY.
  • Eloise Chapman-Davis
    Weill Cornell Medicine, New York, NY.
  • Ravi N Sharaf
    Weill Cornell Medicine, New York, NY.
  • Melissa K Frey
    Weill Cornell Medicine, New York, NY.